Sunday, 20 September 2026European Markets

RAMSAY GEN SANTE And LNA SANTE Have A High Dividend Yield And Return On Equity In The Medical Care Facilities Industry.

Loading stream...

(vianews) - ramsay gen sante (gds.pa) is among this list of stock assets with the highest dividend rate and return on equity on the medical care facilities industry.

financial asset price forward dividend yield return on equity
ramsay gen sante (gds.pa) €19.65 18.41% 5.08%
lna sante (lna.pa) €21.65 2.54% 9.08%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ramsay gen sante (gds.pa)

18.41% forward dividend yield and 5.08% return on equity

ramsay générale de santé sa operates hospitals in france. its hospitals offer a range of services in the areas of anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology, as well as thoracic, vascular, and endovascular surgeries. the company was formerly known as générale de santé sa and changed its name to ramsay générale de santé sa in december 2015. ramsay générale de santé sa was founded in 1987 and is based in paris, france. ramsay générale de santé sa operates as a subsidiary of ramsay health care limited.

earnings per share

as for profitability, ramsay gen sante has a trailing twelve months eps of €0.93.

pe ratio

ramsay gen sante has a trailing twelve months price to earnings ratio of 21.13. meaning, the purchaser of the share is investing €21.13 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.08%.

dividend yield

according to morningstar, inc., the next dividend payment is on dec 2, 2014, the estimated forward annual dividend rate is 2.8 and the estimated forward annual dividend yield is 18.41%.

volume

today's last reported volume for ramsay gen sante is 470 which is 38.23% above its average volume of 340.

more news about ramsay gen sante.

2. lna sante (lna.pa)

2.54% forward dividend yield and 9.08% return on equity

lna santé sa engages in the management and operation of health establishments. the company operates retirement homes, medical and rehabilitation care, home hospital, mental health clinic, and health center. lna santé sa was founded in 1990 and is based in vertou, france.

earnings per share

as for profitability, lna sante has a trailing twelve months eps of €2.28.

pe ratio

lna sante has a trailing twelve months price to earnings ratio of 9.5. meaning, the purchaser of the share is investing €9.5 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.08%.

more news about lna sante.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com